Survival extrapolation in cancer immunotherapy: a validation-based case study

Bullement, A., Latimer, N.R. orcid.org/0000-0001-5304-5585 and Bell Gorrod, H. (2018) Survival extrapolation in cancer immunotherapy: a validation-based case study. Value in Health. ISSN 1098-3015

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © 2018 ISPOR - The Professional Society for Health Economics and Outcomes Research. This is an author produced version of a paper subsequently published in Value in Health. Uploaded in accordance with the publisher's self-archiving policy. Article available under the terms of the CC-BY-NC-ND licence (https://creativecommons.org/licenses/by-nc-nd/4.0/).
Keywords: Immune-checkpoint inhibitor; immunotherapy; survival analysis; survival extrapolation
Dates:
  • Accepted: 13 December 2018
  • Published (online): 13 December 2018
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > School of Health and Related Research (Sheffield) > Sheffield Centre for Health and Related Research
Depositing User: Symplectic Sheffield
Date Deposited: 16 Jan 2019 12:30
Last Modified: 16 Jan 2019 12:30
Published Version: https://doi.org/10.1016/j.jval.2018.10.007
Status: Published online
Publisher: Elsevier
Refereed: Yes
Identification Number: https://doi.org/10.1016/j.jval.2018.10.007

Download

Accepted Version


Embargoed until: 13 December 2019

Filename: ViH accepted version-1.pdf

Licence: CC-BY-NC-ND 4.0

Request a copy

Share / Export

Statistics